IRIS Accounts Production v25.4.12.37 Other Company accounts True false Pounds 1.7.24 30.6.25 30.6.25 FY FRS 102 Unaudited Small companies regime for accounts Full Charities SORP true true true false true false true 0 0 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 10239445 2024-06-30 10239445 2025-06-30 10239445 2024-07-01 2025-06-30 10239445 2023-06-30 10239445 2023-07-01 2024-06-30 10239445 2024-06-30 10239445 ns0:CharitableCompanyLimitedByGuarantee 2024-07-01 2025-06-30 10239445 ns15:PoundSterling 2024-07-01 2025-06-30 10239445 ns11:FRS102 2024-07-01 2025-06-30 10239445 ns11:AuditExempt-NoAccountantsReport 2024-07-01 2025-06-30 10239445 ns11:SmallCompaniesRegimeForAccounts 2024-07-01 2025-06-30 10239445 ns11:FullAccounts 2024-07-01 2025-06-30 10239445 ns0:CharitiesSORP 2024-07-01 2025-06-30 10239445 ns16:EnglandWales 2024-07-01 2025-06-30 10239445 ns11:RegisteredOffice 2024-07-01 2025-06-30 10239445 ns0:Trustee1 2024-07-01 2025-06-30 10239445 ns0:Activity9 2024-07-01 2025-06-30 10239445 ns0:Activity9 2023-07-01 2024-06-30 10239445 ns10:WithinOneYear 2025-06-30 10239445 ns10:WithinOneYear 2024-06-30 10239445 ns0:TotalUnrestrictedFunds 2025-06-30 10239445 2 2024-07-01 2025-06-30

REGISTERED COMPANY NUMBER: 10239445 (England and Wales)

REGISTERED CHARITY NUMBER: 1194121

| Report of the Trustees and |

| Unaudited Financial Statements |

| for the Year Ended 30 June 2025 |

| for |

| GLOBAL OSTEOPOROSIS FOUNDATION |

GLOBAL OSTEOPOROSIS FOUNDATION

Contents of the Financial Statements

for the Year Ended 30 June 2025

| Page |

Report of the Trustees | 1 |  | to |  | 2

Statement of Financial Activities | 3 |

Balance Sheet | 4 |  | to |  | 5

Notes to the Financial Statements | 6 |  | to |  | 10

GLOBAL OSTEOPOROSIS FOUNDATION (REGISTERED NUMBER: 10239445)

Report of the Trustees

for the Year Ended 30 June 2025

The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 30 June 2025. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).

OBJECTIVES AND ACTIVITIES

Objectives and aims

Global Osteoporosis Foundation's objective is to render Osteoporosis a prevented disease globally by 2040. To do this we aim to improve education and understanding of the importance of bone health to everyone by working with educational establishments, governments, national health providers and interested businesses to introduce cost effective screening programmes that can identify and treat sufferers, or potential sufferers, earlier. By doing this we will reduce the huge personal impact to individuals, their families as well as the wider financial burden of caring for and supporting sufferers in the medium and longer term.

The Foundation has advanced its objectives in the year both in terms of refining content that can be distributed to interested parties and preparing a suitable website to demonstrate more fully the activities of the Foundation.

In the coming period these activities will be further developed and formally launched following beta testing, which has been going on in the background throughout the last period, principally through the generosity of Google. Sponsors will be also sought now to promote the objectives with purpose and alacrity. This will allow the recruitment of suitably trained staff and limited overheads to be incurred and expensed.

STRUCTURE, GOVERNANCE AND MANAGEMENT

Governing document

The charity is controlled by its governing document, a deed of trust, and constitutes a limited company, limited by guarantee, as defined by the Companies Act 2006.

REFERENCE AND ADMINISTRATIVE DETAILS

Registered Company number

10239445 (England and Wales)

Registered Charity number

1194121

Registered office

50 Jermyn Street

London

SW1Y 6LX

GLOBAL OSTEOPOROSIS FOUNDATION (REGISTERED NUMBER: 10239445)

Report of the Trustees

for the Year Ended 30 June 2025

Trustees

Dr T Mahmud

J J May

V J Hayes

Mrs C Bell (resigned 1.4.2025)

Mrs C Crathern (resigned 1.2.2026)

Miss A Turner (appointed 1.2.2026)

This report has been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.

Approved by order of the board of trustees on 23 March 2026 and signed on its behalf by:

Dr T Mahmud - Trustee

GLOBAL OSTEOPOROSIS FOUNDATION

Statement of Financial Activities

for the Year Ended 30 June 2025

2025 | 2024 |

Unrestricted |  |

fund | Total funds |

| Notes | £ | £

INCOME AND ENDOWMENTS FROM

Donations and legacies | 10,114 |  | 2,187 |

EXPENDITURE ON

Charitable activities

Charitable |

| 10,164 |  | 3,054 |

NET INCOME/(EXPENDITURE) | (50 | ) | (867 | )

RECONCILIATION OF FUNDS

Total funds brought forward | (307 | ) | 560 |

TOTAL FUNDS CARRIED FORWARD | (357 | ) | (307 | )

GLOBAL OSTEOPOROSIS FOUNDATION (REGISTERED NUMBER: 10239445)

Balance Sheet

30 June 2025

2025 | 2024 |

Unrestricted |  |

fund | Total funds |

| Notes | £ | £

CURRENT ASSETS |

Cash at bank | 368 |  | 368 |

CREDITORS |

Amounts falling due within one year | 4 | (725 | ) | (675 | )

NET CURRENT ASSETS/(LIABILITIES) | (357 | ) | (307 | )

TOTAL ASSETS LESS CURRENT LIABILITIES | (357 | ) | (307 | )

NET ASSETS/(LIABILITIES) | (357 | ) | (307 | )

FUNDS | 5

Unrestricted funds | (357 | ) | (307 | )

TOTAL FUNDS | (357 | ) | (307 | )

The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2025 in accordance with Section 476 of the Companies Act 2006.

The trustees acknowledge their responsibilities for

(a) | ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.

GLOBAL OSTEOPOROSIS FOUNDATION (REGISTERED NUMBER: 10239445)

Balance Sheet - continued

30 June 2025

These financial statements have been prepared in accordance with and delivered in accordance with the special provisions applicable to small charitable companies subject to the small companies regime.

The financial statements were approved by the Board of Trustees and authorised for issue on 23 March 2026 and were signed on its behalf by:

T Mahmud - Trustee

GLOBAL OSTEOPOROSIS FOUNDATION

Notes to the Financial Statements

for the Year Ended 30 June 2025

1. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Income

| All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.

| Expenditure

| Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

| Taxation

| The charity is exempt from corporation tax on its charitable activities.

| Fund accounting

| Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

| Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

| Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

GLOBAL OSTEOPOROSIS FOUNDATION

Notes to the Financial Statements - continued

for the Year Ended 30 June 2025

2. | TRUSTEES' REMUNERATION AND BENEFITS

| There were no trustees' remuneration or other benefits for the year ended 30 June 2025 nor for the year ended 30 June 2024.

| Trustees' expenses

| There were no trustees' expenses paid for the year ended 30 June 2025 nor for the year ended 30 June 2024.

3. | COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES

Unrestricted |

fund |

| £

| INCOME AND ENDOWMENTS FROM

| Donations and legacies | 2,187 |

| EXPENDITURE ON

| Charitable activities

| Charitable |

|  | 3,054 |

| NET INCOME/(EXPENDITURE) | (867 | )

| RECONCILIATION OF FUNDS

| Total funds brought forward | 560 |

| TOTAL FUNDS CARRIED FORWARD | (307 | )

GLOBAL OSTEOPOROSIS FOUNDATION

Notes to the Financial Statements - continued

for the Year Ended 30 June 2025

4. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025 | 2024 |

| £ | £

| Accruals and deferred income | 725 |  | 675 |  |

5. | MOVEMENT IN FUNDS

Net |  |

movement |  |

At 1/7/24 | in funds | At 30/6/25 |

£ | £ | £ |

| Unrestricted funds

| General fund | (307 | ) | (50 | ) | (357 | ) |

| TOTAL FUNDS | (307 | ) | (50 | ) | (357 | ) |

| Net movement in funds, included in the above are as follows:

Incoming | Resources | Movement |

resources | expended | in funds |

£ | £ | £ |

| Unrestricted funds

| General fund | 10,114 |  | (10,164 | ) | (50 | ) |

| TOTAL FUNDS | 10,114 |  | (10,164 | ) | (50 | ) |

| Comparatives for movement in funds

Net |  |

movement |  |

At 1/7/23 | in funds | At 30/6/24 |

£ | £ | £ |

| Unrestricted funds

| General fund | 560 |  | (867 | ) | (307 | ) |

| TOTAL FUNDS | 560 |  | (867 | ) | (307 | ) |

GLOBAL OSTEOPOROSIS FOUNDATION

Notes to the Financial Statements - continued

for the Year Ended 30 June 2025

5. | MOVEMENT IN FUNDS - continued

| Comparative net movement in funds, included in the above are as follows:

Incoming | Resources | Movement |

resources | expended | in funds |

£ | £ | £ |

| Unrestricted funds

| General fund | 2,187 |  | (3,054 | ) | (867 | ) |

| TOTAL FUNDS | 2,187 |  | (3,054 | ) | (867 | ) |

| A current year 12 months and prior year 12 months combined position is as follows:

Net |  |

movement |  |

At 1/7/23 | in funds | At 30/6/25 |

£ | £ | £ |

| Unrestricted funds

| General fund | 560 |  | (917 | ) | (357 | ) |

| TOTAL FUNDS | 560 |  | (917 | ) | (357 | ) |

| A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:

Incoming | Resources | Movement |

resources | expended | in funds |

£ | £ | £ |

| Unrestricted funds

| General fund | 12,301 |  | (13,218 | ) | (917 | ) |

| TOTAL FUNDS | 12,301 |  | (13,218 | ) | (917 | ) |

GLOBAL OSTEOPOROSIS FOUNDATION

Notes to the Financial Statements - continued

for the Year Ended 30 June 2025

6. | RELATED PARTY DISCLOSURES

| There were no related party transactions for the year ended 30 June 2025.